Xeris Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Xeris Pharmaceuticals

Access the complete profile.

Xeris Pharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 44611 Pharmacies & Drug Stores
Address	1375 W Fulton St Ste 1300 Chicago, IL 60607

Note: Revenues for privately held companies are statistical evaluations.


Xeris Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Xeris Pharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Xeris Pharmaceuticals is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Xeris Pharmaceuticals Annual Revenue and Growth Rate

Xeris Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Xeris Pharmaceuticals's revenues are gauged from an analysis of company filings.

Xeris Pharmaceuticals's Income Statement (based on Industry Averages)

Xeris Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Xeris Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
May 22, 2017	22	67%	$45 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Xeris Pharmaceuticals is developing and marketing. Xeris Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
GVOKE VIALDX pharmaceutical preparations for in vivo diagnostic use; pharmaceutical preparations for diagnostic radiology use	09/01/2023
MYGLUCA HYPOPEN Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases	06/22/2018
MYGLUCA Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases	06/22/2018

See all trademarks and details in the Full Report.

Market Share of Xeris Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Xeris Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Xeris Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
FERMI RESEARCH ALLIANCE	Chicago, IL	100
PHARMACANN	Chicago, IL	33
XERIS PHARMACEUTICALS	Chicago, IL	20
HEALTH UTILITY NETWORK	Chicago, IL	13
CHAPIN HALL CENTER FOR CHILDREN	Chicago, IL	9
IIT RESEARCH INSTITUTE	Chicago, IL	6

Future Competition: Xeris Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Xeris Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)